GENFIT Announces 2026 Financial Calendar

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial calendar for 2026. 2026 Financial Calendar February 26, 2026Publication of revenue and cash position at December 31, 2025April 2, 2026Publication of Full Year 2025 financial statements The 2025 Universal Registration ...